Search Results 31-40 of 27582 for monoclonal antibody

  1. Mayo Clinic Comprehensive Cancer Center — Research

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... GA101 is an anti-CD20 humanized and glyco-engineered monoclonal antibody ...

  2. A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in ...

  3. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

    A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

  4. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving copanlisib and nivolumab may work better ...

  5. A Study to Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies to treat participants who have relapsed or refractory multiple myeloma.

  6. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...

  7. Mayo Clinic Comprehensive Cancer Center — Research

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

  8. Monoclonal gammopathy of undetermined significance (MGUS) - Symptoms and causes - Mayo Clinic

    When bone marrow produces an unusual protein in the blood, it can sometimes lead to certain types of blood cancer.

  9. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may ...

  10. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...